Paper40916664
Generation of mice with combined Hexa Gly269Ser KI or KO and Neu3 KO alleles to create new models of GM2 gangliosidoses.
Barker EN and 16 others. Biol Open, 2025. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Generation of mice with combined Hexa Gly269Ser KI or KO and Neu3 KO alleles to create new models of GM2 gangliosidoses. Papers, record 40916664. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40916664
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Generation of mice with combined Hexa Gly269Ser KI or KO and Neu3 KO alleles to create new models of GM2 gangliosidoses.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Disease Models, Animal | Major topic |
| Alleles | Major topic |
| Gangliosidoses, GM2 | Major topic |
| beta-Hexosaminidase alpha Chain | Major topic |
| Animals | |
| Mice | |
| Mice, Knockout | |
| Phenotype | |
| CRISPR-Cas Systems | |
| Gene Knock-In Techniques | |
| Mutation | |
| Humans | |
| N-Acetylgalactosaminyltransferases |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CIHR | Canada | PubMed | ||
| Research Manitoba | PubMed | |||
| Autism Speaks | United States | PubMed | ||
| Natural Sciences and Engineering Council of Canada | PubMed |
Source PubMed
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9169471 | Benign HEXA mutations, C739T(R247W) and C745T(R249W), cause beta-hexosaminidase A pseudodeficiency by reducing the alpha-subunit protein levels. | J Biol Chem | 1997 | https://conductscience.org/library/papers/9169471 | PubMed |
| 2 | 16698036 | Crystallographic structure of human beta-hexosaminidase A: interpretation of Tay-Sachs mutations and loss of GM2 ganglioside hydrolysis. | J Mol Biol | 2006 | https://conductscience.org/library/papers/16698036 | PubMed |
| 3 | 3167861 | Generation of two murine monoclonal antibodies that can discriminate N-glycolyl and N-acetyl neuraminic acid residues of GM2 gangliosides. | Cancer Res | 1988 | https://conductscience.org/library/papers/3167861 | PubMed |
| 4 | 28974375 | Murine Sialidase Neu3 facilitates GM2 degradation and bypass in mouse model of Tay-Sachs disease. | Exp Neurol | 2018 | https://conductscience.org/library/papers/28974375 | PubMed |
| 5 | 32951593 | GM2 ganglioside accumulation causes neuroinflammation and behavioral alterations in a mouse model of early onset Tay-Sachs disease. | J Neuroinflammation | 2020 | https://conductscience.org/library/papers/32951593 | PubMed |
| 6 | 28171706 | Subregional brain distribution of simple and complex glycosphingolipids in the mucopolysaccharidosis type I (Hurler syndrome) mouse: impact of diet. | J Neurochem | 2017 | https://conductscience.org/library/papers/28171706 | PubMed |
| 7 | 27638582 | Lysosphingolipids and sphingolipidoses: Psychosine in Krabbe's disease. | J Neurosci Res | 2016 | https://conductscience.org/library/papers/27638582 | PubMed |
| 8 | 25742564 | Use of the Open Field Maze to measure locomotor and anxiety-like behavior in mice. | J Vis Exp | 2015 | https://conductscience.org/library/papers/25742564 | PubMed |
| 9 | 25515709 | Long-term correction of Sandhoff disease following intravenous delivery of rAAV9 to mouse neonates. | Mol Ther | 2015 | https://conductscience.org/library/papers/25515709 | PubMed |
| 10 | 8789434 | Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases. | Hum Mol Genet | 1996 | https://conductscience.org/library/papers/8789434 | PubMed |
| 11 | 39514043 | Abnormally accumulated GM2 ganglioside contributes to skeletal deformity in Tay-Sachs mice. | J Mol Med (Berl) | 2024 | https://conductscience.org/library/papers/39514043 | PubMed |
| 12 | 12600700 | The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. | Eur J Pharmacol | 2003 | https://conductscience.org/library/papers/12600700 | PubMed |
| 13 | 35675020 | Sialidase NEU3 and its pathological significance. | Glycoconj J | 2022 | https://conductscience.org/library/papers/35675020 | PubMed |
| 14 | 14972652 | Late onset Tay-Sachs disease in mice with targeted disruption of the Hexa gene: behavioral changes and pathology of the central nervous system. | Brain Res | 2004 | https://conductscience.org/library/papers/14972652 | PubMed |
| 15 | 34450229 | The GM2 gangliosidoses: Unlocking the mysteries of pathogenesis and treatment. | Neurosci Lett | 2021 | https://conductscience.org/library/papers/34450229 | PubMed |
| 16 | 18611415 | Early deficits in motor coordination and cognitive dysfunction in a mouse model of the neurodegenerative lysosomal storage disorder, Sandhoff disease. | Behav Brain Res | 2008 | https://conductscience.org/library/papers/18611415 | PubMed |
| 17 | 11331008 | Identification of the 6-sulfate binding site unique to alpha-subunit-containing isozymes of human beta-hexosaminidase. | Biochemistry | 2001 | https://conductscience.org/library/papers/11331008 | PubMed |
| 18 | 37871851 | Sialidase NEU3 action on GM1 ganglioside is neuroprotective in GM1 gangliosidosis. | J Lipid Res | 2023 | https://conductscience.org/library/papers/37871851 | PubMed |
| 19 | 39752451 | Intracerebroventricular administration of a modified hexosaminidase ameliorates late-stage neurodegeneration in a GM2 mouse model. | PLoS One | 2025 | https://conductscience.org/library/papers/39752451 | PubMed |
| 20 | 1870982 | Simplified mammalian DNA isolation procedure. | Nucleic Acids Res | 1991 | https://conductscience.org/library/papers/1870982 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42511849 | Modeling Tay-Sachs Disease in Astrocyte-like Cells Reveals Significant Changes in the Transcriptomic Profile. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42511849 | PubMed |
| 41947150 | A novel humanized mouse model exhibits neurobehavioral impairments and recapitulates key neuropathological features of infantile Tay-Sachs disease. | J Neuroinflammation | 2026 | https://conductscience.org/library/papers/41947150 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40916664
GET https://conductscience.org/api/papers/v1/40916664/references?page=2